ACTRN12623000438651招募中Unknown
The evaluation of treatment outcomes for methamphetamine dependence in Aotearoa New Zealand
niversity of Auckland0 个研究点目标入组 320 人开始时间: 2023年5月1日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 320
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Methamphetamine is the main drug of concern
- •Participants are aged 18 years of age or over
- •Participants have no severe cognitive disability that may affect their capacity to take part
- •Participants live in the Northland, Auckland, or Waikato regions of New Zealand.
- •Participants in the in-treatment-group will include those who have been admitted to treatment within the last two weeks of been screened for the study.
- •Participants in the Not-In-Treatment-Group [NITG] will include those who at the time of screening where not involved in formal treatment. NITG participants at screening will need to score 4 or more on the Severity of Substance Dependence Scale (SDS)
排除标准
- •People who, in the last 30 days, have received any treatment for methamphetamine /amphetamine use, any in-patient drug treatment or imprisonment. NB: Participants in treatment will not be eligible to participate in this study if they received any treatment for methamphetamine /amphetamine use (any in-patient drug treatment or imprisonment, in the 30 days prior to starting the current treatment episode).
研究者
相似试验
已完成
3 期
The effect of magnesium in patients with attention deficit hyperactivity disorderIRCT20160813029327N19Islamic Azad University62
进行中（未招募）
1 期
Etude d’efficacité et d’acceptabilité du méthylphénidate dans les troubles de la marche de la maladie de Parkinson : Etude multicentrique en double aveugle versus placebo. - PARGKAIT IIEUCTR2008-005801-20-FRCentre Hospitalier Régional et Universitaire de Lille69
进行中（未招募）
不适用
To evaluate the effectiveness of MetaDerm Cream in Atopic DermatitisCTRI/2017/06/008950Haus Bioceuticals Inc
已完成
4 期
A clinical trial to study the effects of two drugs, Metformin Immediate Release and Metformin Extended Release in newly diagnosed type 2 diabetes mellitus patients.CTRI/2021/04/033194Bangalore Medical College and Research Institute70
招募中
3 期
Metformin and Body Mass Index of Patients under Treatment with SSRICondition 1: Obesity. Condition 2: Depression. Condition 3: Anxiety Disorders.Drug-induced obesityMajor depressive disorder, single episode, severe without psychotic featuresOther anxiety disordersE66.1F32.2IRCT20140102016035N3Rasht University of Medical Sciences60